Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Blinded, LT Dose-ranging Study to Assess the Immunogenicity and Safety of Different Doses of LT Adjuvant Patch Administered in Conjunction With Different Doses of Inactivated Influenza A/H5N1 Vaccine in Healthy Adults

NCT00908687 is registered in ClinicalTrials.gov with Intercell USA, Inc. as lead sponsor.

NCT NCT00908687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00908687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Blinded, LT Dose-ranging Study to Assess the Immunogenicity and Safety of Different Doses of LT Adjuvant Patch Administered in Conjunction With Different Doses of Inactivated Influenza A/H5N1 Vaccine in Healthy Adults
Lead sponsor
Intercell USA, Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2009
Completion date
July 31, 2011
Enrollment
500 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pandemic influenza